I am currently designing a sandwich ELISA experiment and would like to inquire about the feasibility and potential challenges of using polyclonal antibody serum from the same species as both the capture and detection antibody. Specifically:

  • Can polyclonal antibodies derived from the same species be reliably used for both capture and detection without significant interference?
  • Are there common issues, such as cross-reactivity or background signal, associated with this setup?
  • Would it be advisable to label the detection antibody (e.g., HRP) or use a secondary anti-species antibody for signal generation to minimize potential issues?
  • Any guidance, relevant literature, or best practices to optimize this configuration would be greatly appreciated.

    More Umar ALi Younis's questions See All
    Similar questions and discussions